IBUPROFEN
NDC 59556-764, IBUPROFEN, capsule, liquid filled, from Strides Pharma Inc.
- Product NDC
- 59556-764
- Status
- Listed
- Labeler
- Strides Pharma Inc
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA204469
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59556-764 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN200 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59556-764-11 | 59556076411 | 1 BOTTLE in 1 CARTON (59556-764-11) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-12 | 59556076412 | 1 BOTTLE in 1 CARTON (59556-764-12) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-13 | 59556076413 | 1 BOTTLE in 1 CARTON (59556-764-13) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-18 | 59556076418 | 1 BOTTLE in 1 CARTON (59556-764-18) / 180 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-29 | 59556076429 | 1 BOTTLE in 1 CARTON (59556-764-29) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-48 | 59556076448 | 1 BOTTLE in 1 CARTON (59556-764-48) / 160 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-49 | 59556076449 | 1 BOTTLE in 1 CARTON (59556-764-49) / 200 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-50 | 59556076450 | 1 BOTTLE in 1 CARTON (59556-764-50) / 300 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| 59556-764-92 | 59556076492 | 3000 CAPSULE, LIQUID FILLED in 1 BAG (59556-764-92) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 59556-764 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59556-764 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59556-764. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.